Home > Banner Home > Blog > COES en la Prensa > Noticias > Los costos de la demencia en una país desigual, publicación COES-GERO en El Mercurio

Blog

marzo 14, 2017

Los costos de la demencia en una país desigual, publicación COES-GERO en El Mercurio

Hoy El Mercurio publicó una nota sobre “Los costos de las demencia en un país desigual, el caso de Chile” (Título original: “The cost of dementia in an unequal country: The case of Chile“), publicado hace una semana en la revista PLOS ONE de los investigadores Daniel Hojman y Fabían Duarte, ambos COES y académicos de la Facultad de Economía y Negocios de la Universidad de Chile, junto a Jaime Ruiz-Tagle, economista FEN, UChile; Marilu Budnich, Centro KINTUN, Servicio de Salud Metropolitano Oriente, Santiago; Carolina Delgado, Departamento Neurología y Neurocirugía de Hospital Clínico U.Chile y de Clínica Santa María; Andrea Slachevsky, Departamento de Fisiopatología, U.Chile; Fondap GERO | Geroscience Center for Brain Health and Metabolism, Santiago; asociada a Hospital El Salvador, Clínica Alemana y CIAE, UChile.

Este artículo, escrito por economistas y neurólogos chilenos, reúne a investigadores del Fondap COES (Daniel Hojman y Fabían Duarte) y del Fondap GERO (Andrea Slachevsky).

“La falta de un sistema de acceso universal  para la demencia está volviéndose una pesada carga económica, laboral y en salud mental para las familias, en especial las más pobres” (El Mercurio).

Ver nota completa en El Mercurio

El Mercurio, el cuidado de familiares representa 75% del costo de las demencias

El Mercurio, el cuidado de familiares representa 75% del costo de las demencias

Abstract “The cost of dementia in an unequal country: The case of Chile

We study the economic cost of dementia in Chile, and its variation according to socioeconomic status (SES). We use primary data from a survey of 330 informal primary caregivers who completed both a RUD-Lite and a socio-demographic questionnaire to evaluate the severity of dementia and caregiver’s burden. The costs of dementia are broken into three components: direct medical costs (medical care, drugs, tests); direct social costs (social service, daycare); and indirect costs (mostly associated to informal care). The average monthly cost per patient is estimated at US$ 1,463. Direct medical costs account for 20 per cent, direct social costs for 5 per cent and indirect costs for 75 per cent of the total cost. The mean monthly cost is found to be inversely related to SES, a pattern largely driven by indirect costs. The monthly cost for high SES is US$ 1,083 and US$ 1,588 for low SES. A multivariate regression analysis suggests that severity of dementia and caregiver’s burden account for between 49 and 70 per cent of the difference in the indirect cost across SES. However, between one-third and one-half of the variation across SES is not due to gradient in severity of dementia. Direct medical costs increase in higher SES, reflecting differences in purchasing power, while indirect costs are inversely related to SES and more than compensate differences in medical costs. Moreover, in lower SES groups, female caregivers, typically family members who are inactive in the labor market, mostly provide informal care. The average annual cost of dementia in Chile (US$ 17,559) is lower in comparison to highincome countries (US$ 39,595) and the proportion of cost related to informal cost is higher (74 per cent compared to 40 per cent). SES is a key determinant in the cost of dementia. In the absence of universal access to treatment, part of the social cost of dementia potentially preserves or increases income and gender inequality.

VER PUBLICACIÓN “The cost of dementia in an unequal country: The case of Chile”